Epigenic Therapeutics Raises $60 Million to Boost Epigenetic Drugs
September 8, 2025
Epigenic Therapeutics, a clinical-stage biotech company specializing in epigenetic-based drug development, has secured $60 million in a Series B funding round. The round was led